Nesfatin-1 stimulates fatty-acid oxidation by activating AMP-activated protein kinase in STZ-induced type 2 diabetic mice.

PLoS One · 2013 · PMC3877039 · PMID 24391760

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

showed a trendno p-value reported

Though difference between DML, DMH and DMN groups did not reach statistical significance, nesfatin-1 injected mice showed a trend toward a dose-related decrease in plasma FFA levels (DML 2.57±0.34 mmol/L vs.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.